[artículo] 
inJournal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 1 (Febrero) . - pp. 40-43

Título :	Comparison of topiramate and risperidone for the treatment of behavioral disturbances of patients with alzheimer disease : A double blind, randomized clinical trial
Tipo de documento:	texto impreso
Autores:	Arash Mowla, Autor ; Azadeh Pani, Autor
Fecha de publicación:	2022
Artículo en la página:	pp. 40-43
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Alzheimer, Alteración del comportamiento, Topiramato
Resumen:	Behavioral disturbances are determining factors in handling patients with Alzheimer dementia. The current pharmacotherapy for behavioral symptoms associated with dementia is not satisfactory. Our goal was to compare a new anticonvulsant, topiramate, with a usually used medication, risperidone, for controlling behavioral disturbances of patients with Alzheimer dementia.
Link:	./index.php?lvl=notice_display&id=29469

[artículo] Comparison of topiramate and risperidone for the treatment of behavioral disturbances of patients with alzheimer disease : A double blind, randomized clinical trial [texto impreso] / Arash Mowla, Autor ; Azadeh Pani, Autor . - 2022 . - pp. 40-43.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 1 (Febrero) . - pp. 40-43

Palabras clave:	Alzheimer, Alteración del comportamiento, Topiramato
Resumen:	Behavioral disturbances are determining factors in handling patients with Alzheimer dementia. The current pharmacotherapy for behavioral symptoms associated with dementia is not satisfactory. Our goal was to compare a new anticonvulsant, topiramate, with a usually used medication, risperidone, for controlling behavioral disturbances of patients with Alzheimer dementia.
Link:	./index.php?lvl=notice_display&id=29469